Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Metastatic Solid Tumors × Infusions, Intravenous × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia, Myeloid, Acute 2 Solid Tumors 1 Recurrence 1 Myelodysplastic Syndromes 1 Metastatic Solid Tumors 1 Leukemia, Myelomonocytic, Chronic 1 Advanced Malignant Neoplasm 1

Interventions

Platinum 1 Infusions, Intravenous 1 FANG vaccine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07272590 2025-12-09

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting

Other solid neoplasm

Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡